Mammography vendor Lorad of Danbury, CT, has signed an exclusivemultiyear agreement with breast biopsy instrument supplier U.S.Surgical that could be worth up to $10 million to Lorad in thefirst year of the contract. Under the terms of the deal,
Mammography vendor Lorad of Danbury, CT, has signed an exclusivemultiyear agreement with breast biopsy instrument supplier U.S.Surgical that could be worth up to $10 million to Lorad in thefirst year of the contract. Under the terms of the deal, Loradwill supply stereotactic equipment such as its StereoGuide coreneedle biopsy system to U.S. Surgical for use with that company'sAdvanced Breast Biopsy Instrument (ABBI) system. ABBI employsa one-step procedure to both place a wire marker in the breastand remove a tissue specimen for biopsy.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.